Addison Advisors’s Quest Diagnostics DGX Stock Holding History

Addison Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$274K	Hold	1,400	–	–	0.06%	181
2025 Q4	$243K	Hold	1,400	–	–	0.05%	189
2025 Q3	$267K	Hold	1,400	–	–	0.06%	184
2025 Q2	$251K	Buy	1,400 +100	+8%	+$17.4K	0.06%	183
2025 Q1	$220K	Hold	1,300	–	–	0.06%	191
2024 Q4	$196K	Buy	1,300 +125	+11%	+$19.4K	0.05%	209
2024 Q3	$182K	Hold	1,175	–	–	0.05%	229
2024 Q2	$161K	Hold	1,175	–	–	0.05%	231
2024 Q1	$156K	Hold	1,175	–	–	0.05%	229
2023 Q4	$162K	Hold	1,175	–	–	0.06%	205
2023 Q3	$143K	Hold	1,175	–	–	0.07%	200
2023 Q2	$165K	Hold	1,175	–	–	0.08%	177
2023 Q1	$166K	Sell	1,175 -3	-0.3%	-$429	0.09%	156
2022 Q4	$184K	Hold	1,178	–	–	0.11%	135
2022 Q3	$145K	Hold	1,178	–	–	0.09%	152
2022 Q2	$157K	Hold	1,178	–	–	0.1%	146
2022 Q1	$161K	Hold	1,178	–	–	0.09%	156
2021 Q4	$204K	Buy	1,178 +3	+0.3%	+$456	0.13%	116
2021 Q3	$171K	Hold	1,175	–	–	0.14%	86
2021 Q2	$155K	Buy	+1,175	New	+$154K	0.13%	97
2020 Q4	$160K	Buy	+1,345	New	+$164K	0.15%	95

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Addison Advisors's DGX Position: Q1 2026 in Review

Addison Advisors held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,400 shares worth $274K. The position accounts for 0.06% of the portfolio, ranked #181.

Addison Advisors first reported a position in DGX in Q4 2020 and has held it in 21 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Addison Advisors held 1,400 shares of Quest Diagnostics worth $274K as of Q1 2026.
Addison Advisors left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.06% of Addison Advisors's portfolio in Q1 2026, its #181 holding.
Addison Advisors first reported a position in Quest Diagnostics in Q4 2020 and has held it in 21 quarters since.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.